Get your personalised estimate in 30 seconds
Move the sliders to see how your age, treatment choice, and individual factors affect your real-world chance of a live birth.
We won't quote you a single 70% success rate number. Instead, we'll show you exactly what the world's three biggest fertility registries — HFEA, SART and ESHRE — say about your specific situation.
Move the sliders to see how your age, treatment choice, and individual factors affect your real-world chance of a live birth.
Almost every fertility clinic quotes a success rate. The numbers look reassuringly large — 60%, 70%, sometimes 90%. So why do half of IVF patients leave their first cycle without a baby? Because the denominator does almost all the work.
One embryo is placed into the uterus. If no embryo ever reaches transfer (because no egg fertilised or no embryo developed), that complete cycle simply disappears from the success statistic. The transfer is an already-filtered selection — and that filtering hides the hardest failures.
Every cycle that starts with stimulation is counted — whether or not it reaches transfer. This includes cancelled cycles, failed retrievals and cycles with no transfer. <em>The gap between per-transfer and per-cycle rates is typically 10 to 20 percentage points.</em>
When we say donor egg IVF in Prague has a 47% live birth rate per embryo transfer, you should ask: per transfer or per cycle started? (Per transfer.) Live birth or clinical pregnancy? (Live birth.) Every number on this page uses the same definition. No marketing arithmetic.
The single most important variable in IVF, explained.
The single most important variable in IVF is the age of the egg, not the age of the uterus. This is the most under-explained fact in fertility, and the one that opens up an entire alternative path for women over 38.
A 25-year-old egg has roughly a 75% chance of being chromosomally normal. By age 35, that drops to about 50%. By 43, it's around 24%. Most of the age-related decline in IVF success is caused by chromosomal errors in the egg.
This is why donor egg IVF transforms outcomes for women over 38. The eggs come from young donors (18 to 32 in the Czech Republic, most aged 22 to 28). The pregnancy is yours.
The right treatment depends on your medical situation, age, and priorities. Here's how the three options compare, including the trade-offs we wish more clinics talked about openly.
Every patient's situation is different. Talk to a specialist to find out which path fits your specific diagnosis, age and goals.
Book Your Free Strategy CallTwo countries lead European egg donation: Spain and Czech Republic. Both perform more donor cycles than the UK, Germany and France combined. But Czech Republic has specific structural advantages rooted in law, not marketing.
Czech Act No. 373/2011 mandates strict mutual anonymity between donor and recipient. Donor supply has stayed abundant.
Most patients begin treatment 4 to 6 weeks after consultation. The UK currently has an 8+ month wait at most clinics.
Czech Republic performs roughly 3,130 IVF cycles per million inhabitants — third highest in Europe.
Among the highest rates in the EU. The country is structurally set up for IVF.
Donors undergo medical, genetic, infectious disease and psychological evaluation. Roughly 40% pass all stages.
PGT-A is one of the most heavily marketed IVF add-ons in Europe. It can genuinely help in specific situations. It can also be deeply misleading. Here is how to tell which applies to you.
PGT-A is one tool among many. A specialist can tell you if it makes sense for your specific situation.
Discuss Your Results in a Free Strategy CallThe UK fertility regulator, HFEA, maintains a traffic-light rating system for IVF add-ons. As of 2024, not a single add-on holds a green rating for improving live birth in the general IVF population. We follow the evidence.
We don't sell add-ons. We only recommend what the evidence says works for your specific case. We'd rather be honest than charge you for something that doesn't help.
Cost is the practical reason most international patients consider Prague. Here's the honest cross-country comparison for a complete donor egg cycle.
| Country | Cost note | Typical price (full donor egg IVF) |
|---|---|---|
| United Kingdom | NHS: limited by postcode (27% of cycles funded) | £8,000 to £15,000+ |
| Ireland | HSE: 1 cycle free for eligible patients | Private only |
| Germany | Egg donation not legal | Travel required |
| Netherlands | Insurance: 3 cycles under 43 | €5,000 to €8,000 |
| Sweden | Public, age cutoff 42, 3 to 4 year waits | €4,000 to €7,000 |
| United States | Limited; varies by state | $35,000 to $60,000+ |
| Czech Republic (Praga Medica) | — | From €4,980 |
A personal IVF coordinator guides you through every step. Multilingual (English, German). Reachable on WhatsApp, email or phone.
Praga Medica has worked with international patients since 2010. We understand the practical realities of cross-border care.
We work with established Czech IVF clinics regulated by SÚKL and reporting to NRAR.
The calculator gives an evidence-based estimate based on registry data from HFEA (UK), SART (US) and ESHRE (Europe), adjusted for the factors you enter. It's accurate for population-level estimates but cannot replace a full medical assessment. Your individual results depend on factors like ovarian reserve (AMH, AFC), embryo quality, sperm quality and uterine health that only a specialist can evaluate.
Three reasons. First, healthcare costs in general are lower in Czech Republic, including specialist salaries, clinic real estate and laboratory supplies. Second, public funding for IVF in Czech Republic creates volume, which lowers per-cycle cost. Third, our market is competitive: there are 48 IVF centres in a country of 10.5 million people. Quality has to be high or patients go elsewhere.
Yes. All Czech IVF clinics are licensed and regulated by SÚKL (the Czech State Institute for Drug Control), comply with EU Tissues and Cells Directive 2004/23/EC, and report to NRAR (National Registry of Assisted Reproduction). Donor screening follows EU and ESHRE guidelines.
A typical donor egg cycle from first consultation to embryo transfer takes 4 to 8 weeks. You'll usually need one visit to Prague of 5 to 7 days for the synchronisation and transfer phase. Embryo donation cycles can be slightly shorter (no donor cycle synchronisation needed).
Most patients budget for 2 to 3 cycles. Our cumulative success rates are based on this — single-cycle outcomes are not the right frame for fertility treatment. We discuss multi-cycle planning openly during consultation and offer multi-cycle packages with progressive discounts.
Unfortunately Czech law currently restricts IVF treatment to heterosexual couples. We'll be transparent: Spain is the standard alternative for single women and same-sex couples. We're happy to refer you to reputable Spanish clinics if your situation requires this.
Donors are anonymous women aged 18 to 32, with most in their early-to-mid twenties. They undergo medical, genetic, infectious-disease and psychological screening. Roughly 40% of applicants pass all stages. Matching is done on physical characteristics: hair colour, eye colour, blood type, height, body type and skin tone. Under Czech law donor photos are not provided to recipients.
No. Czech law mandates lifelong mutual anonymity for both donor and recipient. This is different from UK law, where children can identify their donor at age 18.
Surplus embryos can be cryopreserved (frozen) for use in subsequent cycles. Annual storage fees apply after year one. You can also donate them to other patients via the embryo donation programme. This is your decision and is documented in writing before treatment.
No referral is required. Many patients self-refer after researching their options. If you have previous test results from UK or other clinics, please share them, they help us avoid duplicate tests.
Methodology: The calculator's success rate estimates use population-level data from HFEA, SART and ESHRE registries. Individual factors (BMI, smoking status, diagnosis, prior cycles) adjust the baseline rate using published odds ratios. All estimates are presented as ranges. Actual clinical outcomes vary.